Evidera: New unit for PPD after Evidera acquisition

Following its acquisition of Bethesda, Maryland-based Evidera last year, Pharmaceutical Product Development has rolled out a new business unit that combines its medical affairs research operations team. The new unit will be known as Evidera, PPD announced Monday, and will be led by Evidera President and CEO Jon Williams. "The new unit will enable us to help our clients seamlessly integrate and align regulatory and post-approval research efforts, creating a smooth transition from Phase III to...